Dr. Majeed Foundation supports COVID-19 efforts in India, donating over $1.32M
The Dr. Majeed Foundation has donated significantly to the PM CARES Fund and Karnataka State Disaster Management Autority, in India, to support COVID-19 relief efforts.
Image courtesy of Dr. Majeed Foundation
Since the outbreak of COVID-19, the Dr. Majeed Foundation (Bengaluru, India) has contributed US $1.32M to the Prime Minister's Citizen Assistance and Relief in Emergency Situations Fund (PM CARES Fund)—a fund created in India to combat, contain, and offer relief efforts against COVID-19 and any future related events—and over $250,000 to the Karnataka State Disaster Management Authority. PM CARES Fund has been able to supply 50,000 ventilators, care of migrant laborers, and financial support for a vaccine development.
“We have always believed in supporting the less fortunate while giving back to society and the nation,” said Muhammed Majeed, PhD, founder and chairman of Sami-Sabinsa Group and founder of Dr. Majeed Foundation, in a press release. “Today, as the COVID-19 pandemic poses an unprecedented challenge for the country, supporting efforts such as the PM CARES Fund is a step toward helping combat the virus.”
More recently, the Foundation gave out 3,600 kits with essential food items, protective equipment, hand sanitizers, and health supplements in Bengaluru and Hyderabad. Teams from Sami Labs helped to distribute the items.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
